Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study Talquetamab + teclistamab in patients with triple-class exposed R/R MM and EMD: The RedirecTT-1 study June 2025 Congress News Read more
2020 April Corona Haematological disorders during corona times: listing the risks and consequences Read more
2020 April Healthy Living Mediterranean diet linked to better gut biome and associated health benefits in elderly Read more
2020 April Healthy Living Health benefits of walking depend more on number of steps taken than on speed Read more
Top
